---
title: "Omkar Pharmachem Ltd (532167) — Share Price, Financials & Analysis"
symbol: "532167"
company: "Omkar Pharmachem Ltd"
canonical: "https://tapetide.com/stocks/532167"
isin: "INE501C01015"
nse_symbol: "OMKARPHARMACHEMLTD"
bse_code: "532167"
sector: "Chemicals"
industry: "Commodity Chemicals"
market_cap_cr: 7.24
generated_at: "2026-09-13T19:43:20.144Z"
---

# Omkar Pharmachem Ltd (532167)

Canonical page: https://tapetide.com/stocks/532167

## Company

- **NSE Symbol:** OMKARPHARMACHEMLTD
- **BSE Code:** 532167
- **ISIN:** INE501C01015
- **Sector:** Chemicals
- **Industry:** Commodity Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2006-11-23
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** omkarpharmachem.co.in

## About

Incorporated in 1995, Omkar Pharmachem Ltd provides business support services.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:36:01.955286Z.

- **Market Cap:** ₹7.24 Cr
- **Classification:** Microcap
- **P/E (reported):** 94.6
- **EPS (TTM):** ₹0.09
- **Book Value:** ₹36.33
- **Price to Book:** 0.21
- **Dividend Yield:** 0%
- **ROE:** 0.33%
- **ROCE:** 0.45%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0.5 Cr
- **Net Income:** ₹0.1 Cr
- **EBITDA:** ₹0.2 Cr
- **52-Week High:** ₹29.74
- **52-Week Low:** ₹7.57
- **RSI (14):** 13.53

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.21 times its book value
- Debtor days have improved from 41.6 to 23.3 days.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 11.7% over past five years.
- Promoter holding is low: 0.03%
- Company has a low return on equity of 1.23% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -4.17% | -23.33% | 15% |
| ebitda margin growth | 0% | -33.92% | -32.52% | -28.31% |
| net income growth | 0% | -50% | -16% | -11% |
| revenue growth | 0% | 0% | -5% | 12% |
| roce | — | -85.2% | -85.25% | 2.6% |
| roe | — | -84.51% | 1.5% | -84.06% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.11 | 0.09 | 0.09 |
| Expenses | 0.05 | 0.07 | 0.06 | 0.09 | 0.05 | 0.05 | 0.07 | 0.1 | 0.07 | 0.07 | 0.07 | 0.1 |
| Operating Profit | 0.09 | 0.07 | 0.08 | 0.05 | 0.09 | 0.09 | 0.07 | 0.04 | 0.07 | 0.04 | 0.02 | -0.01 |
| OPM % | 64.29 | 50 | 57.14 | 35.71 | 64.29 | 64.29 | 50 | 28.57 | 50 | 36.36 | 22.22 | -11.11 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.09 | 0.07 | 0.05 | 0.05 | 0.09 | 0.09 | 0.05 | 0.04 | 0.07 | 0.04 | 0.02 | -0.01 |
| Tax % | 0 | 0 | 120 | 0 | 0 | 0 | 140 | 25 | 28.57 | 25 | 0 | 0 |
| Net Profit | 0.09 | 0.07 | -0.02 | 0.05 | 0.09 | 0.08 | -0.02 | 0.03 | 0.05 | 0.03 | 0.02 | -0.01 |
| EPS in Rs | 0.09 | 0.07 | -0.02 | 0.05 | 0.09 | 0.08 | -0.02 | 0.03 | 0.05 | 0.03 | 0.02 | -0.01 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0.05 | 0.27 | 0.54 | 0.54 | 0.54 | 0.54 | 0.47 | 0.43 |
| Expenses | 0.24 | 0.38 | 0.26 | 0.24 | 0.27 | 0.22 | 0.25 | 0.24 | 0.31 | 0.31 |
| Operating Profit | -0.24 | -0.38 | -0.21 | 0.03 | 0.27 | 0.32 | 0.29 | 0.3 | 0.16 | 0.12 |
| OPM % | — | — | -420 | 11.11 | 50 | 59.26 | 53.7 | 55.56 | 34.04 | 27.91 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| Interest | 0.01 | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | 0.03 | 0.02 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 |
| Profit before tax | -0.25 | -0.42 | -0.26 | -0.03 | 0.21 | 0.27 | 0.26 | 0.27 | 0.17 | 0.12 |
| Tax % | 0 | 0 | 0 | -866.67 | 14.29 | 25.93 | 23.08 | 25.93 | 23.53 | — |
| Net Profit | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.2 | 0.19 | 0.2 | 0.12 | 0.09 |
| EPS in Rs | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.2 | 0.19 | 0.2 | 0.12 | 0.09 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
| Reserves | -0.71 | -0.96 | -1.38 | -1.64 | -1.42 | -1.24 | -1.04 | -0.85 | -0.65 | 26.56 |
| Borrowings | 0 | 0.24 | 0.58 | 0.87 | 0.9 | 0.93 | 0.62 | 0.3 | 0.12 | 0 |
| Other Liabilities | 0.06 | 0.04 | 0.05 | 0.06 | 0.08 | 0.06 | 0.07 | 0.07 | 0.05 | 0.05 |
| Total Liabilities | 9.43 | 9.4 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.6 | 9.6 | 36.69 |
| Fixed Assets | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 9.3 | 9.3 | 9.3 | 9.3 | 9.3 | 9.3 | 9.3 | 9.3 | 9.3 | 36.38 |
| Other Assets | 0.13 | 0.09 | 0.03 | 0.07 | 0.34 | 0.52 | 0.43 | 0.29 | 0.29 | 0.31 |
| Total Assets | 9.43 | 9.4 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.6 | 9.6 | 36.69 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.77 | -0.25 | -0.3 | -0.21 | 0.02 | 0.2 | 0.28 | 0.3 | 0.24 | 0.23 |
| Cash from Investing Activity | 0.49 | -0.01 | 0 | 0 | 0 | -0.01 | 0 | -0.01 | 0 | 0 |
| Cash from Financing Activity | 0.01 | 0.23 | 0.3 | 0.24 | -0.02 | -0.03 | -0.35 | -0.35 | -0.2 | -0.12 |
| Net Cash Flow | -0.28 | -0.03 | 0 | 0.02 | 0 | 0.17 | -0.08 | -0.06 | 0.04 | 0.11 |
| Free Cash Flow | -0.29 | -0.26 | -0.3 | -0.21 | 0.02 | 0.19 | 0.28 | 0.29 | 0.24 | 0.23 |
| CFO/OP | 327 | 104 | 79 | 100 | 67 | 74 | 88 | 103 | 80 | 150 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | — | — | 146 | 40.56 | 54.07 | 87.87 | 33.8 | 67.59 | 23.3 |
| Cash Conversion Cycle | — | — | — | 146 | 40.56 | 54.07 | 87.87 | 33.8 | 67.59 | 23.3 |
| Working Capital Days | — | — | — | -6570 | -1270.74 | -608.33 | -378.52 | -162.22 | -6.76 | 23.3 |
| ROCE % | -2.27 | -2.56 | -4.08 | -2.26 | 0.32 | 2.79 | 3.29 | 3.02 | 3.04 | 0.74 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% |
| Others | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% |
| No. of Shareholders | 3590 | 3600 | 3601 | 3609 | 3608 | 3609 | 3611 | 3619 | 3618 | 3618 | 3617 | 3669 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 6 / 1 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 8.98 | Sell |
| EMA (10) | 8.93 | Sell |
| SMA (20) | 10.6 | Sell |
| EMA (20) | 10.49 | Sell |
| SMA (50) | 14.39 | Sell |
| EMA (50) | 14.11 | Sell |
| SMA (100) | 20.28 | Sell |
| EMA (100) | 17.38 | Sell |
| SMA (200) | 21.56 | Sell |
| EMA (200) | 18.23 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 13.25 | Buy |
| MACD (12,26,9) | -2.05 | Sell |
| Stochastic (14,3,3) | 1.8 | Buy |
| ADX (14) | 49.06 | Buy |
| Williams %R (14) | -94.6 | Buy |
| ATR (14) | 0.7 | High Volatility |
| ROC (12) | -35.78 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 10.83 | Buy |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cd0a360-efe0-4be1-9eee-d24841978cb1.pdf) |
| 2026-09-02 | [Shareholders Meeting-AGM-September 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61daca6d-8176-4611-a74e-62c81b37b35c.pdf) |
| 2026-09-02 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15a8684c-5c83-40bf-9f01-788949807cab.pdf) |
| 2026-09-02 | [Corporate Action-Fixes Record Date For 31St AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab83965e-127d-4928-b922-f7db2cd5299c.pdf) |
| 2026-08-31 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 31St August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7aeab9e3-4f28-4867-91b9-79760da7fd37.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7de1ecc1-aa76-4399-ac34-4b617754567e.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d6e7997-3483-42f5-a7b2-d68b7479b0f3.pdf) |
| 2026-08-06 | [Board Meeting Intimation for Intimation Of The Board Meeting Of The Company Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=092cc3e4-42c9-4ca8-a641-eb426a4c871f.pdf) |
| 2026-07-18 | [Newspaper Publication Regarding Special Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd3f6371-b403-4786-9992-5d12f7e1d04f.pdf) |
| 2026-07-13 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3265080-cdd8-4a8f-91cc-1c377a5d308d.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Unaudited Financial Results For The Quarter Ended On 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3192f1e2-915c-4202-aa6e-f2e5c9df1779.pdf) |
| 2026-05-30 | [Financial Results For The Quarter And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bebc4d5-bbdb-488a-b5e4-a3bc9a07f174.pdf) |
| 2026-02-14 | [Unaudited Financial Results For The Quarter And Nine Months Ended On 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b8d2cda-1cd9-479f-a4ed-639159c6530d.pdf) |
| 2025-11-14 | [Results- Unaudited Financial Results For September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4cd7db1-74ff-4729-8ae5-2d007b6ab63e.pdf) |
| 2025-08-13 | [Results- Financial Results For June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fc3ae9e-2748-478b-873e-303dde0d213c.pdf) |
| 2025-05-29 | [Results- Financial Results For March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fdf5e92-030b-4030-96af-ca4ced4cdda0.pdf) |
| 2025-02-14 | [Financial Results For December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16a08a4e-7548-47cf-b1a0-542be59c11b3.pdf) |
| 2024-11-12 | [Results- Financial Results For September 30 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba29c41a-4b25-4f0e-be08-02e0c9949c4f.pdf) |
| 2024-08-12 | [Board Meeting Intimation For Consideration And Approval Unaudited Financial Results Of The Company For The Quarter Ended On June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dba67169-89af-434c-9f44-78733becfd57.pdf) |
| 2024-05-30 | [Results- Financial Results For March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=523bf052-5905-4310-9858-61c1a5cbb175.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 February 2026 - Auditor reviewed Lagnam Spintex unaudited financials for quarter and nine months ended 31 Dec 2025. | [Outcome of Board Meeting 7 February 2026 - Auditor reviewed Lagnam Spintex unaudited financials for quarter and nine months ended 31 Dec 2025.](https://nsearchives.nseindia.com/corporate/LAGNAM_07022026141914_OutcomeOfBoardMeeting07022026.pdf) |
| 7 February 2026 - A.L. Chechani & Co reviewed Lagnam Spintex unaudited results for quarter and nine months ended 31 Dec 2025; no issues. | [General Updates 7 February 2026 - A.L. Chechani & Co reviewed Lagnam Spintex unaudited results for quarter and nine months ended 31 Dec 2025; no issues.](https://nsearchives.nseindia.com/corporate/LAGNAM_07022026143959_OutcomeUpdate070226.pdf) |
| 16 Feb - Dear Sir, Please find Newspaper Advertisement for the Unaudited Financial Results for the quarter and nine months ended on 31.12.2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb - Dear Sir, Please find Newspaper Advertisement for the Unaudited Financial Results for the quarter and nine months ended on 31.12.2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/707758cf-cee7-4804-9db4-4d970ae4bfd3.pdf) |
| 16 Feb - Clarification: Independent Director Janak Raj Sharma ceased effective 12-Feb-2026; intimation filed 14-Feb-2026. | [Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015 16 Feb - Clarification: Independent Director Janak Raj Sharma ceased effective 12-Feb-2026; intimation filed 14-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/708c4bb1-debf-423f-9523-0a6ca30ab9e8.pdf) |
| 14 Feb - Omkar Pharmachem files unaudited results for quarter/nine months ended 31-12-2025: nine-month profit Rs 10.68 lakh | [Unaudited Financial Results For The Quarter And Nine Months Ended On 31.12.2025 14 Feb - Omkar Pharmachem files unaudited results for quarter/nine months ended 31-12-2025: nine-month profit Rs 10.68 lakh](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9b8d2cda-1cd9-479f-a4ed-639159c6530d.pdf) |
| 14 Feb - Board approved unaudited Q3/nine-month results to 31-Dec-2025; Independent Director Janak Raj Sharma ceased 12-Feb-2026. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February, 2026 14 Feb - Board approved unaudited Q3/nine-month results to 31-Dec-2025; Independent Director Janak Raj Sharma ceased 12-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d08b6dc-8e41-4ffd-b4cd-7453c823ad95.pdf) |
| 13 Apr - Regulation 74(5) certificate filed for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Apr - Regulation 74(5) certificate filed for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d754e6f0-faef-47d6-8b11-3948bafd2290.pdf) |
| 12 Feb - Report for SEBI special-window (1–6 Jan 2026): no re-lodgement requests received or processed. | [Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests From 01St January, 2026 To 06Th January 2026 12 Feb - Report for SEBI special-window (1–6 Jan 2026): no re-lodgement requests received or processed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/490e867c-f143-4d6f-a1a0-a65006882e0c.pdf) |
| 11 November 2025 - Published unaudited Q2 and H1 financial results for period ended 30 Sep 2025. | [Copy of Newspaper Publication 11 November 2025 - Published unaudited Q2 and H1 financial results for period ended 30 Sep 2025.](https://nsearchives.nseindia.com/corporate/LAGNAM_11112025185849_NewspaperPublication300925Results.pdf) |
| 10 November 2025 - Lagnam Spintex approved unaudited Q2/H1 results to 30 Sept 2025: H1 revenue Rs272.53 crore, PAT Rs2.35 crore | [Outcome of Board Meeting 10 November 2025 - Lagnam Spintex approved unaudited Q2/H1 results to 30 Sept 2025: H1 revenue Rs272.53 crore, PAT Rs2.35 crore](https://nsearchives.nseindia.com/corporate/LAGNAM_10112025143452_OUTCOMEANDFRSEP25_101125.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/AR_26665_LAGNAM_2024_2025_A_01072025164557.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/AR_24177_LAGNAM_2023_2024_24062024182658.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/AR_22178_LAGNAM_2022_2023_04072023202131_07042023210004.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/AR_20027_LAGNAM_2021_2022_07062022101806_06072022110004.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e9a98aa0-e0d6-456e-a283-86db4b72e9bd.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/58a68ace-ea33-4db0-800a-e58a21007eee.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15f89b28-38df-4d77-aabd-6a3380d0028b.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532167/75375532167.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532167/70847532167.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532167/65609532167.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:43:20.144Z.